PlainRecalls
FDA Drug Low Class III Terminated

HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01

Reported: November 19, 2014 Initiated: April 14, 2014 #D-0247-2015

Product Description

HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01

Reason for Recall

Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.

Details

Recalling Firm
Fresenius Kabi USA LLC
Units Affected
216,517 vials
Distribution
Nationwide and Puerto Rico
Location
Melrose Park, IL

Frequently Asked Questions

What product was recalled?
HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01. Recalled by Fresenius Kabi USA LLC. Units affected: 216,517 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 19, 2014. Severity: Low. Recall number: D-0247-2015.